SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

Share Price is delayed by 15 minutes
Get Live Data
1,240.00    30.00 (2.46%)
Bid:
1,230.00
Ask:
1,250.00
Spread: 20.00 (1.626%)
Market Cap: £369.26m
CER Live PriceLast checked at - London Stock Exchange

Intraday Cerillion Share Chart

Trading Update

24 Oct 2022 07:00

RNS Number : 7831D
Cerillion PLC
24 October 2022
 

AIM: CER

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

 Cerillion plc

("Cerillion" or "the Company")

 

Trading Update

 

Cerillion, the billing, charging and customer relationship management software solutions provider, is pleased to announce an update on trading for the financial year ended 30 September 2022.

 

Cerillion entered the second half of the financial year with a strong back-order book* and continued to trade very well throughout the period, including securing the Company's largest contract to date in the fourth quarter. During the period, the Company benefitted significantly from favourable foreign exchange rates and higher resource utilisation, as well as lower net finance costs and lower depreciation and amortisation than anticipated. As a consequence, whilst revenue is expected to be marginally ahead of market expectations, adjusted profit before tax for the financial year is now expected to be materially ahead of the consensus market forecast of £10.1m. Net cash at 30 September 2022 is anticipated to close strongly at approximately £20.0m (30 September 2021: £13.2m), which is also ahead of market expectations.

 

The pipeline of new business opportunities, from both existing and prospective new customers, remains buoyant and the Company is well-positioned as it enters the new financial year.

 

The Board intends to announce full year results in late November 2022, when the Company will provide a further update on current trading. 

 

*Back-order book consists of sales contracted but not yet recognised as revenue at the end of the reporting period plus annualised support and maintenance revenue.

 

 

Cerillion plc

c/o KTZ Communications

Louis Hall, CEO

T: 020 3178 6378

Andrew Dickson, CFO

Liberum (Nomad and Broker)

T: 020 3100 2000

Bidhi Bhoma, Cameron Duncan, William Hall

Singer Capital Markets (Joint Broker)

T: 020 7496 3000

Rick Thompson, George Tzimas, James Fischer

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis, Dan Mahoney

 

About Cerillion

www.cerillion.com

 

Cerillion is a leading provider of mission critical software for billing, charging and customer relationship management ("CRM"), mainly serving the telecommunications market but also other sectors such as utilities and financial services. The Company currently has c.80 customer installations across c.44 countries. Headquartered in London, Cerillion also has operations in India, where its Global Solutions Centre is located, Australiaand Bulgaria.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGZMZGNMLGZZM
Date   Source Headline
7th Feb 20209:57 amRNSResult of AGM
8th Jan 20208:58 amRNSHolding(s) in Company
8th Jan 20207:00 amRNSNotice of AGM
27th Nov 20192:52 pmRNSHolding(s) in Company
25th Nov 20197:00 amRNSFinal Results
20th Nov 20197:00 amRNSHolding(s) in Company
28th Oct 20197:00 amRNSTrading Update
14th Oct 20197:00 amRNSMajor Contract Win
26th Sep 20194:49 pmRNSHolding(s) in Company
9th Sep 20197:00 amRNSMajor New Contract Win
8th Aug 20194:14 pmRNSHolding(s) in Company
8th Aug 20194:13 pmRNSHolding(s) in Company
28th Jun 20197:00 amRNSHolding(s) in Company
25th Jun 20197:00 amRNSMajor Contract Win
14th Jun 20197:00 amRNSMajor New Contract Win
20th May 20197:00 amRNSInterim Results
2nd May 20197:00 amRNSTrading Update and Notice of Results
21st Feb 20197:00 amRNSGartner Magic Quadrant Report
14th Feb 20194:01 pmRNSEmployee Share Option Scheme
13th Feb 20197:00 amRNSMajor New Contract Win
8th Feb 20193:16 pmRNSResult of AGM
25th Jan 20196:03 pmRNSNotice of AGM
26th Nov 20187:00 amRNSFinal Results
22nd Oct 20187:00 amRNSTrading Update
30th May 20187:00 amRNSTM Forum's 2018 Catalyst Awards
14th May 20187:00 amRNSInterim Results
16th Apr 20187:25 amRNSTrading Update & Notice of Results
5th Feb 201810:21 amRNSResult of AGM
17th Jan 20187:00 amRNSNotice of AGM and Posting of Annual Report
5th Dec 20177:00 amRNSMajor Contract Win
27th Nov 20177:00 amRNSFinal Results
17th Nov 20177:00 amRNSChange of Registered Office
30th Oct 20177:00 amRNSGartner Magic Quadrant Report
30th Oct 20177:00 amRNSTrading Update
20th Sep 20174:33 pmRNSHolding(s) in Company
19th Sep 20174:39 pmRNSImplementation of Long Term Incentive Plan
26th May 201710:13 amRNSCompletion of Director Placing
25th May 20175:00 pmRNSProposed Director Placing
22nd May 20177:00 amRNSInterim Results
9th May 20177:00 amRNSNotice of Results
10th Apr 20177:00 amRNSTrading Update
17th Mar 20177:00 amRNSMajor Contract Win
8th Feb 20174:11 pmRNSRe: New Employee Share Option Scheme
11th Jan 20175:47 pmRNSNotice of AGM and Posting of Annual Report
6th Jan 20177:00 amRNSNew Employee Share Option Scheme
21st Dec 20167:00 amRNSMajor Contract Win
1st Dec 20165:38 pmRNSRevised Dividend Timetable
28th Nov 20167:00 amRNSMajor Contract Win
28th Nov 20167:00 amRNSFinal Results
24th Oct 20167:00 amRNSRe: Gartner's 2016 Magic Quadrant report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.